Ligand Pharmaceuticals Total Assets 2006-2020 | LGND

Ligand Pharmaceuticals total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Ligand Pharmaceuticals Annual Total Assets
(Millions of US $)
2019 $1,495
2018 $1,261
2017 $671
2016 $602
2015 $503
2014 $258
2013 $105
2012 $104
2011 $121
2010 $76
2009 $142
2008 $171
2007 $173
2006 $326
2005 $315
Ligand Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2020-06-30 $1,243
2020-03-31 $1,186
2019-12-31 $1,495
2019-09-30 $1,547
2019-06-30 $1,802
2019-03-31 $1,914
2018-12-31 $1,261
2018-09-30 $2,106
2018-06-30 $1,858
2018-03-31 $755
2017-12-31 $671
2017-09-30 $662
2017-06-30 $640
2017-03-31 $630
2016-12-31 $602
2016-09-30 $601
2016-06-30 $589
2016-03-31 $586
2015-12-31 $503
2015-09-30 $522
2015-06-30 $305
2015-03-31 $263
2014-12-31 $258
2014-09-30 $272
2014-06-30 $100
2014-03-31 $105
2013-12-31 $105
2013-09-30 $102
2013-06-30 $100
2013-03-31 $98
2012-12-31 $104
2012-09-30 $98
2012-06-30 $103
2012-03-31 $110
2011-12-31 $121
2011-09-30 $122
2011-06-30 $127
2011-03-31 $134
2010-12-31 $76
2010-09-30 $113
2010-06-30 $128
2010-03-31 $134
2009-12-31 $142
2009-09-30 $117
2009-06-30 $129
2009-03-31 $140
2008-12-31 $171
2008-09-30 $147
2008-06-30 $160
2008-03-31 $166
2007-12-31 $173
2007-09-30 $212
2007-06-30 $228
2007-03-31 $525
2006-12-31 $326
2006-09-30 $232
2006-06-30 $286
2006-03-31 $289
2005-12-31 $315
2005-09-30 $306
2005-06-30 $302
2005-03-31 $313
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.426B $0.120B
Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $137.210B 10.56
Amgen (AMGN) United States $135.354B 14.70
CSL (CSLLY) Australia $97.716B 0.00
Gilead Sciences (GILD) United States $75.913B 10.93
Regeneron Pharmaceuticals (REGN) United States $61.349B 23.46
Vertex Pharmaceuticals (VRTX) United States $55.881B 31.18
Illumina (ILMN) United States $46.784B 54.40
Biogen (BIIB) United States $42.289B 7.24
Seattle Genetics (SGEN) United States $34.455B 0.00
Moderna (MRNA) United States $28.138B 0.00
BeiGene (BGNE) Cayman Islands $27.181B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.177B 11.32
Genmab (GMAB) Denmark $23.448B 14.79
Genmab (GNMSF) Denmark $22.360B 5.15
BioNTech SE (BNTX) Germany $21.348B 0.00
Immunomedics (IMMU) United States $20.276B 0.00
Incyte (INCY) United States $19.532B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.071B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.404B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.730B 71.14
Exact Sciences (EXAS) United States $15.470B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.342B 35.90
BioMarin Pharmaceutical (BMRN) United States $14.129B 102.51
ARGENX SE-ADR (ARGX) Netherlands $12.342B 0.00
QIAGEN (QGEN) Netherlands $11.861B 30.10
MyoKardia (MYOK) United States $11.791B 0.00
Sarepta Therapeutics (SRPT) United States $10.795B 0.00
Bio-Techne Corp (TECH) United States $10.198B 69.97
Guardant Health (GH) United States $10.133B 0.00
Repligen (RGEN) United States $9.056B 143.74
Galapagos (GLPG) Belgium $8.611B 31.16
Mirati Therapeutics (MRTX) United States $8.420B 0.00
Ascendis Pharma (ASND) Denmark $8.244B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $7.487B 231.96
Exelixis (EXEL) United States $6.881B 25.02
Acceleron Pharma (XLRN) United States $6.713B 0.00
Adaptive Biotechnologies (ADPT) United States $6.549B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.498B 0.00
Novavax (NVAX) United States $6.027B 0.00
Blueprint Medicines (BPMC) United States $5.664B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.577B 15.24
Ultragenyx Pharmaceutical (RARE) United States $5.453B 0.00
Emergent Biosolutions (EBS) United States $5.118B 20.27
NeoGenomics (NEO) United States $4.721B 1425.00
Vir Biotechnology (VIR) United States $4.505B 0.00
Arena Pharmaceuticals (ARNA) United States $4.484B 0.00
China Biologic Products (CBPO) China $4.472B 26.55
Denali Therapeutics (DNLI) United States $4.397B 0.00
Amicus Therapeutics (FOLD) United States $4.393B 0.00
Fate Therapeutics (FATE) United States $4.185B 0.00
Halozyme Therapeutics (HALO) United States $4.141B 0.00
Twist Bioscience (TWST) United States $3.964B 0.00
Insmed (INSM) United States $3.908B 0.00
Reata Pharmaceuticals (RETA) United States $3.885B 0.00
Bluebird Bio (BLUE) United States $3.642B 0.00
Global Blood Therapeutics (GBT) United States $3.598B 0.00
MorphoSys AG (MOR) Germany $3.538B 46.36
Legend Biotech (LEGN) United States $3.514B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.346B 0.00
Eidos Therapeutics (EIDX) United States $2.826B 0.00
Alkermes (ALKS) Ireland $2.691B 56.40
PHARMA MAR SA (PHMMF) Spain $2.604B 0.00
Seres Therapeutics (MCRB) United States $2.410B 0.00
I-Mab (IMAB) China $2.318B 0.00
Sorrento Therapeutics (SRNE) United States $2.151B 0.00
Editas Medicine (EDIT) United States $2.066B 0.00
Forma Therapeutics Holdings (FMTX) United States $2.012B 0.00
Zymeworks (ZYME) Canada $1.974B 0.00
Amarin (AMRN) Ireland $1.908B 0.00
Inovio Pharmaceuticals (INO) United States $1.843B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Northwest Biotherapeutics (NWBO) United States $1.817B 0.00
UniQure (QURE) Netherlands $1.737B 0.00
Viela Bio (VIE) United States $1.736B 0.00
Intra-Cellular Therapies (ITCI) United States $1.732B 0.00
Revance Therapeutics (RVNC) United States $1.652B 0.00
Zealand Pharma (ZEAL) Denmark $1.604B 0.00
Beam Therapeutics (BEAM) United States $1.580B 0.00
Sangamo Therapeutics (SGMO) United States $1.494B 0.00
Zealand Pharma (ZLDPF) Denmark $1.483B 0.00
Intellia Therapeutics (NTLA) United States $1.430B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.424B 0.00
Epizyme (EPZM) United States $1.397B 0.00
Mesoblast (MESO) Australia $1.393B 0.00
Arcus Biosciences (RCUS) United States $1.255B 0.00
Alcobra (ARCT) United States $1.226B 0.00
Coherus BioSciences (CHRS) United States $1.198B 6.98
Mersana Therapeutics (MRSN) United States $1.183B 0.00
Cytokineticsorporated (CYTK) United States $1.146B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.145B 0.00
NGM Biopharmaceuticals (NGM) United States $1.127B 0.00
Retrophin (RTRX) United States $1.061B 0.00
REGENXBIO (RGNX) United States $1.009B 0.00
Compugen (CGEN) Israel $1.004B 0.00
Myriad Genetics (MYGN) United States $1.003B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.002B 0.00
Genetron Holdings (GTH) China $0.996B 0.00
Heska (HSKA) United States $0.986B 0.00
Athenex (ATNX) United States $0.976B 0.00
Castle Biosciences (CSTL) United States $0.968B 0.00
Adverum Biotechnologies (ADVM) United States $0.941B 0.00
Vericel (VCEL) United States $0.938B 0.00
NantKwest (NK) United States $0.912B 0.00
Codexis (CDXS) United States $0.831B 0.00
Arvinas (ARVN) United States $0.823B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.820B 0.00
Intrexon (PGEN) United States $0.809B 0.00
Pliant Therapeutics (PLRX) United States $0.808B 0.00
Morphic Holding (MORF) United States $0.805B 0.00
Cellectis S.A (CLLS) France $0.768B 0.00
Agenus (AGEN) United States $0.759B 0.00
Alector (ALEC) United States $0.745B 0.00
Protagonist Therapeutics (PTGX) United States $0.741B 0.00
MiMedx (MDXG) United States $0.718B 0.00
AnaptysBio (ANAB) United States $0.704B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.701B 0.00
Cara Therapeutics (CARA) United States $0.697B 0.00
Frequency Therapeutics (FREQ) United States $0.695B 0.00
Pharming Group (PHGUF) Netherlands $0.692B 15.79
Sinovac Biotech (SVA) China $0.640B 43.13
Celldex Therapeutics (CLDX) United States $0.637B 0.00
Kadmon Holdings (KDMN) United States $0.635B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.630B 0.00
VBI Vaccines (VBIV) United States $0.603B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Geron (GERN) United States $0.574B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.562B 4.92
Cel-Sci (CVM) United States $0.532B 0.00
IVERIC Bio (ISEE) United States $0.527B 0.00
Albireo Pharma (ALBO) United States $0.523B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.520B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.520B 0.00
Anika Therapeutics (ANIK) United States $0.513B 22.44
Clovis Oncology (CLVS) United States $0.505B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.486B 0.00
MeiraGTx Holdings (MGTX) United States $0.483B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.471B 0.00
MannKind (MNKD) United States $0.461B 0.00
Avid Bioservices (CDMO) United States $0.459B 0.00
Dynavax Technologies (DVAX) United States $0.453B 0.00
UROGEN PHARMA (URGN) United States $0.452B 0.00
Prothena (PRTA) Ireland $0.449B 0.00
Kala Pharmaceuticals (KALA) United States $0.437B 0.00
Sutro Biopharma (STRO) United States $0.433B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.433B 0.00
Amryt Pharma (AMYT) United Kingdom $0.433B 0.00
Starpharma Holdings (SPHRY) Australia $0.431B 0.00
Cue Biopharma (CUE) United States $0.417B 0.00
Scholar Rock Holding (SRRK) United States $0.411B 0.00
Forte Biosciences (FBRX) United States $0.389B 0.00
Merus (MRUS) Netherlands $0.382B 0.00
Kamada (KMDA) Israel $0.377B 18.00
Puma Biotechnology (PBYI) United States $0.375B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.374B 0.00
Trevena (TRVN) United States $0.366B 0.00
Syros Pharmaceuticals (SYRS) United States $0.360B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.359B 0.00
Cellular Biomedicine (CBMG) United States $0.358B 0.00
IBio (IBIO) United States $0.352B 0.00
ANI Pharmaceuticals (ANIP) United States $0.344B 8.13
Spero Therapeutics (SPRO) United States $0.344B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.342B 0.00
BioDelivery Sciences (BDSI) United States $0.334B 23.64
AC Immune SA (ACIU) Switzerland $0.334B 0.00
Precision BioSciences (DTIL) United States $0.333B 0.00
Athersys (ATHX) United States $0.322B 0.00
NextCure (NXTC) United States $0.317B 0.00
Cardiff Oncology (CRDF) United States $0.316B 0.00
Innate Pharma S.A (IPHA) France $0.315B 0.00
CytomX Therapeutics (CTMX) United States $0.310B 0.00
ChromaDex (CDXC) United States $0.304B 0.00
WAVE Life Sciences (WVE) Singapore $0.302B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.301B 0.00
Pluristem Therapeutics (PSTI) Israel $0.274B 0.00
Affimed (AFMD) Germany $0.258B 0.00
PDL BioPharma (PDLI) United States $0.252B 0.00
Selecta Biosciences (SELB) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.233B 0.00
Arbutus Biopharma (ABUS) United States $0.233B 0.00
TELA Bio (TELA) United States $0.225B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.221B 0.00
XOMA (XOMA) United States $0.219B 0.00
Verastem (VSTM) United States $0.212B 0.00
HOOKIPA Pharma (HOOK) United States $0.209B 0.00
Five Prime Therapeutics (FPRX) United States $0.208B 0.00
Aptinyx (APTX) United States $0.202B 0.00
Dyadic (DYAI) United States $0.192B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.192B 0.00
Eton Pharmaceuticals (ETON) United States $0.191B 0.00
ADMA Biologics Inc (ADMA) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
CorMedix Inc (CRMD) United States $0.179B 0.00
Cerecor (CERC) United States $0.178B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.174B 0.00
DBV Technologies S.A (DBVT) France $0.174B 0.00
Biofrontera AG (BFRA) Germany $0.170B 0.00
GENFIT S.A (GNFT) France $0.167B 0.00
Theratechnologies (THTX) Canada $0.166B 0.00
Kindred Biosciences (KIN) United States $0.163B 0.00
Liquidia Technologies (LQDA) United States $0.157B 0.00
Exicure (XCUR) United States $0.155B 0.00
VolitionRX (VNRX) United States $0.155B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.150B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Prometic Life Sciences (LMNL) Canada $0.149B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.148B 6.90
Checkpoint Therapeutics (CKPT) United States $0.147B 0.00
Bellus Health (BLU) Canada $0.145B 0.00
SESEN BIO, INC (SESN) United States $0.138B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
AquaBounty Technologies (AQB) United States $0.133B 0.00
Cidara Therapeutics (CDTX) United States $0.128B 0.00
Aytu Bioscience (AYTU) United States $0.127B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.122B 0.00
Windtree Therapeutics (WINT) United States $0.120B 0.00
Protalix BioTherapeutics (PLX) Israel $0.119B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Celyad SA (CYAD) Belgium $0.117B 0.00
Unum Therapeutics (COGT) United States $0.117B 0.00
Strongbridge Biopharma (SBBP) United States $0.116B 0.00
Catalyst Biosciences (CBIO) United States $0.116B 0.00
Lumos Pharma (LUMO) United States $0.113B 0.00
Abeona Therapeutics (ABEO) United States $0.112B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.112B 0.00
Orgenesis (ORGS) United States $0.111B 5.66
Gritstone Oncology (GRTS) United States $0.109B 0.00
Antibe Therapeutics (ATBPF) Canada $0.108B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.104B 0.00
AIT Therapeutics (XAIR) United States $0.103B 0.00
Oncobiologics (OTLK) United States $0.103B 0.00
Enzo Biochem (ENZ) United States $0.097B 0.00
Palatin Technologies (PTN) United States $0.097B 0.00
Cyclerion Therapeutics (CYCN) United States $0.090B 0.00
Evogene (EVGN) Israel $0.089B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
DiaMedica Therapeutics (DMAC) United States $0.081B 0.00
Stealth BioTherapeutics (MITO) United States $0.077B 74.00
Bionano Genomics (BNGO) United States $0.077B 0.00
Idera Pharmaceuticals (IDRA) United States $0.075B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Appili Therapeutics (APLIF) Canada $0.069B 0.00
Adocia (ADOCY) France $0.067B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
AmpliPhi Biosciences (ARMP) United States $0.065B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.064B 0.00
Prima BioMed (IMMP) Australia $0.064B 0.00
Curis (CRIS) United States $0.064B 0.00
Edesa Biotech (EDSA) Canada $0.063B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.061B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.056B 0.00
TRACON Pharmaceuticals (TCON) United States $0.056B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.054B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Genetic Technologies (GENE) Australia $0.046B 0.00
Acorda Therapeutics (ACOR) United States $0.046B 0.00
Cocrystal Pharma (COCP) United States $0.046B 0.00
Happiness Biotech Group (HAPP) China $0.045B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Novogen (KZIA) Australia $0.043B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
Cleveland BioLabs (CBLI) United States $0.041B 0.00
Vaccinex (VCNX) United States $0.039B 0.00
CollPlant Holdings (CLGN) Israel $0.039B 0.00
AnPac Bio-Medical Science (ANPC) China $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.034B 0.00
OvaScience (MLND) United States $0.033B 0.00
Advaxis (ADXS) United States $0.030B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Prana Biotechnology (ATHE) Australia $0.028B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Celsion (CLSN) United States $0.021B 0.00
Spherix (AIKI) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
BioPharmX (TMBR) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.012B 0.00
Titan Pharmaceuticals (TTNP) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00